Current status of natural products from plants as anti-herpes simplex virus 1 agents

Virologica Sinica

Volumn 23, Issue 5, 2008, Pages 305-314

  Xiang, Yang Fei ^a   Pei, Ying ^a   Wang, Yi fei ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Anti HSV 1; Antiviral; Herpes simplex virus 1 (HSV 1); Natural product

Indexed keywords

ANTIVIRUS AGENT; CARISSA EDULIS EXTRACT; CATECHIN; CURCUMIN; DITERPENE; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; FLAVONE DERIVATIVE; FLAVONOL DERIVATIVE; FUCOIDIN; GALACTANE SULFATE; GALLOCATECHIN; GLYCOCONJUGATE; GLYCYRRHIZIC ACID; NATURAL PRODUCT; NOSTOFLAN; NUCLEOSIDE ANALOG; PACLITAXEL DERIVATIVE; PLANT EXTRACT; POLYPHENOL; POLYPHENOL DERIVATIVE; POLYSACCHARIDE; SCHEFFLERA HEPTAPHYLLA EXTRACT; SESQUITERPENE; SP 2A; TERPENE DERIVATIVE; TRITERPENOID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VEGETABLE PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CARISSA EDULIS; CYTOPATHOGENIC EFFECT; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; GENOTOXICITY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; MEDICINAL PLANT; MULTIDRUG RESISTANCE; NONHUMAN; PLANT PRODUCT; SCHEFFLERA HEPTAPHYLLA; SEAWEED; STRUCTURE ACTIVITY RELATION; SULFATION; VERO CELL; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS VIRULENCE;

HUMAN HERPESVIRUS 1;

EID: 54049146675     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-008-2962-7     Document Type: Article

References (49)

1. Adhikari U, Mateu C G, Chattopadhyay K, et al. 2006. Structure and antiviral activity of sulfated fucans from Stoechospermum marginatum. Phytochemistry, 67(22): 2474-2482.
2. Alban S, Franz G. 2002. Partial synthetic glucan sulfates as potential new antithrombotics. Biomacromolecules, 2(2): 354-361.
3. Barbosa J P, Pereira R C, Abrantes J L, et al. 2004. In vitro antiviral diterpenes from the Brazilian brown alga Dictyota pfaffii. Planta Med, 70(9): 856-860.
4. Chattopadhyay K, Mateu C G, Mandal P, et al. 2007. Galactan sulfate of Grateloupia indica: Isolation, structural features and antiviral activity. Phytochemistry, 68(10): 1428-1435.
5. Cooper E L. 2001. Drug discovery, CAM and natural products. eCAM, 1(3): 215-217.
6. Corey L, Adams H G, Brown Z A, et al. 1983. Genital herpes simplex virus infections: Clinical manifestations, course, and complications. Ann Intern Med, 98(6): 958-972.
7. Fatahzadeh M, Schwartz R A. 2007. Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol, 57(5): 737-763.
8. Filho I C, Cortez D A G, Ueda-Nakamura T, et al. 2008. Antiviral activity and mode of action of a peptide isolated from Sorghum bicolor. Phytomedicine, 15(3): 202-208.
9. Fritz D, Venturi C R, Cargnin S, et al. 2007. Herpes virus inhibitory substances from Hypericum connatum Lam., a plant used in southern Brazil to treat oral lesions. J Ethnopharmaco, 113(3): 517-520.
10. Grabley S, Thiericke R. 2000. Drug Discovery from Nature, Berlin: Springer, p3-p37.
11. Groth T, Wagenknecht W. 2001. Anticoagulant potential of regioselective cellulose. Biomaterials, 22(12): 2719-2729.
12. Gu C Q, Li J W, Chao F, et al. 2007. Isolation, identification and function of a novel anti-HSV-1 protein from Grifola frondosa. Antiviral Res, 75(3):250-257.
13. Hayashi K, Nakano T, Hashimoto M, et al. 2008. Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection. Int Immunopharmacol, 8(1): 109-116.
14. Ikeda T, Yokomizo K, Okawa M, et al. 2005. Anti-herpes virus type 1 activity of oleanane-type triterpenoids. Biol Pharm Bull, 28(9): 1779-1781.
15. Isaacs C E, Wen G Y, Xu W, et al. 2008. Epigallocatechin Gallate Inactivates Clinical Isolates of Herpes Simplex Virus. Antimicrob Agents Chemother, 52(3): 962-970.
16. Kalinyak J E, Fleagle G, Docherty J J. 1977. Incidence and distribution of herpes simplex virus types 1 and 2 from genital lesions in college women. J Med Virol, 1(3): 175-181.
17. Kanekiyo K, Hayashi K, Takenaka H, et al. 2007. Anti-herpes simplex virus target of an acidic polysaccharide, nostoflan, from the edible blue-green alga Nostoc flagelliforme. Biol Pharm Bull, 30(8): 1573-1575.
18. Kanekiyo K, Lee J B, Hayashi K, et al. 2005. Isolation of an antiviral polysaccharide, nostoflan, from a terrestrial cyanobacterium, Nostoc flagelliforme. J Nat Prod, 68(7): 1037-1041.
19. Khan M T H, Ather A, Kenneth D, et al. 2005. Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res, 67: 107-119.
20. Krawczyk E, Luczak M, Majewska A. 2005. Antiviral and cytotoxic activities of new derivatives of natural sesquiterpenes and taxol. Med Dosw Mikrobiol, 57(1): 93-99.
21. Krawczyk E, Luczak M, Kniotek M, et al. 2005. Cytotoxic, antiviral (in-vitro and in-vivo), immunomodulatory activity and influence on mitotic divisions of three taxol derivatives: 10-deacetyl-baccatin III, methyl (N-benzoyl-(2′R, 3′S)-3′-phenylisoserinate) and N-benzoyl-(2′R,3′S)-3′-phenylisoserine. J Pharm Pharmacol, 57(6): 791-797.
22. Kutluay S B, Doroghazi J, Roemer M E, et al. 2008. Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology, 373(2): 239-247.
23. Lee J B, Hou X L, Hayashi K, et al. 2007. Effect of partial desulfation and oversulfation of sodium spirulan on the potency of anti-herpetic activities. Carbohyd Polym, 69(4): 651-658.
24. Likhitwitayawuid K, Chaiwiriya S, Sritularak B, et al. 2006. Antiherpetic flavones from the heartwood of Artocarpus gomezianus. Chem Biodivers, 3(10): 1138-1143.
25. Li Y L, Jiang R W, Ooi L S M, et al. 2007. Antiviral Triterpenoids from the Medicinal Plant Schefflera heptaphylla. Phytother Res, 21(5): 466-470.
26. Li Y, Leung K T, Yao F, et al. 2006. Antiviral flavans from the leaves of Pithecellobium clypearia. J Nat Prod, 69(5): 833-835.
27. Li Z, Liu J, Zhao Y. 2005. Possible mechanism underlying the antiherpetic activity of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. J Biochem Mol Biol, 38(1): 34-40.
28. Lindequist U, Niedermeyer T, Jülich W D. 2005. The pharmacological potential of mushrooms. eCAM, 2(3): 28-99.
29. Lyu S Y, Rhim J Y, Park W B. 2005. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch Pharm Res, 28(11): 1293-1301.
30. Manach C, Scalbert A, Morand C, et al. 2004. Polyphenols: Food sources and bioavailability. Am J Clin Nutr, 79(5): 727-747.
31. Mandal P, Mateu C G, Chattopadhyay K, et al. 2007. Structural features and antiviral activity of sulphated fucans from the brown seaweed Cystoseira indica. Antivir Chem Chemother, 18(3): 153-162.
32. Matsuhiro B, Conte A F, Damonte E B, et al. 2005. Structural analysis and antiviral activity of a sulfated galactan from the red seaweed Schizymenia binderi (Gigartinales, Rhodophyta). Carbohydr Res, 340(15): 2392-2402.
33. Müller V, Chávez J H, Reginatto F H, et al. 2007. Evaluation of antiviral activity of South American plant extracts against herpes simplex virus type 1 and rabies virus. Phytother Res, 21(10): 970-974.
34. Newman D J, Cragg G M, Snader K M. 2000. The influence of natural products upon drug discovery. Nat Prod Rep, 17(3): 215-234.
35. Newman D J, Cragg G M. 2007. Natural Products as Sources of New Drugs over the Last 25 Years. J Nat Prod, 70(3): 461-477.
36. Park J, Kurokawa M, Shiraki K, et al. 2005. Antiviral activity of the marine alga Symphyocladia latiuscula against herpes simplex virus (HSV-1) in vitro and its therapeutic efficacy against HSV-1 infection in mice. Biol Pharm Bull, 28(12): 2258-2262.
37. Pujol C A, Scolaro L A, Ciancia M, et al. 2006. Antiviral activity of a carrageenan from Gigartina skottsbergii against intraperitoneal murine herpes simplex virus infection. Planta Med, 72(2): 121-125.
38. Savi L A, Barardi C R M, Simões C M O. 2006. Evaluation of Antiherpetic Activity and Genotoxic Effects of Tea Catechin Derivatives. J Agric Food Chem, 54(7): 2552-2557.
39. Soares A R, Abrantes J L, Lopes Souza T M, et al. 2007. In vitro antiviral effect of meroditerpenes isolated from the Brazilian seaweed Stypopodium zonale (Dictyotales). Planta Med, 73(11): 1221-1224.
40. Spector F C, Liang L, Giordano H, et al. 1998. Inhibition of Herpes Simplex Virus Replication by a 2-Amino Thiazole via Interactions with the Helicase Component of the UL5-UL8-UL52 Complex. J Virol, 72(9): 6979-6987.
41. Tolo F M, Rukunga G M, Muli F W, et al. 2006. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus. J Ethnopharmacol, 104(1-2): 92-99.
42. Uozaki M, Yamasaki H, Katsuyama Y, et al. 2007. Antiviral effect of octyl gallate against DNA and RNA viruses. Antiviral Res, 73(2): 85-91.
43. Wiart C, Kumar K, Yusof M Y, et al. 2005. Antiviral properties of ent-labdene diterpenes of Andrographis paniculata nees, inhibitors of herpes simplex virus type 1. Phytother Res, 19(12): 1069-1070.
44. Yang C M, Cheng H Y, Lin T C, et al. 2007. The in vitro activity of geraniin and 1,3,4,6-tetra- O -galloyl-β-D-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection. J Ethnop-harmaco, 110(3): 555-558.
45. Yamaguchi K, Honda M, Ikigai H, et al. 2002. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res, 53(1): 19-34.
46. Yoosook C, Chantratita W, Rimdusit P. 1989. Recovery frequencies of herpes simplex virus Types 1 and 2 from symptomatic and asymptomatic genital herpes cases and antiviral sensitivities of isolates. J Med Assoc Thailand, 72(10): 572-576.
47. Zhang Y, But P P, Ooi V E, et al. 2007. Chemical properties, mode of action, and in vivo anti-herpes activities of a lignin-carbohydrate complex from Prunella vulgaris. Antiviral Res, 75(3): 242-249.
48. Zhu W, Chiu L C M, Ooi V E C, et al. 2006. Antiviral property and mechanisms of a sulphated polysaccharide from the brown alga Sargassum patens against Herpes simplex virus type 1. Phytomedicine, 13(9-10): 695-701.
49. Ziyaeyan M, Alborzi A, Japoni A, et al. 2007. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome. Int J Dermatol, 46(12): 1263-1266.